Pioneer Hi Bred International issued US patent for 'maize variety hybrid X08B813'

ALEXANDRIA, Virginia , January 28, 2014 () – United States Patent no. 8,637,747, issued on Jan. 28, was assigned to Pioneer Hi Bred International Inc (Johnston, Iowa).

"Maize variety hybrid X08B813" was invented by Thomas Charles Barker (Greeley, Colo.), Timothy James Masek (Seward, Neb.), Lora Lynn Kilgore-Norquest (Garden City, Kan.) and Travis J. Lee (Hanston, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel maize variety designated X08B813 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing hybrid maize variety X08B813 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X08B813 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety X08B813, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X08B813. This invention further relates to methods for producing maize varieties derived from maize variety X08B813."

The patent was filed on March 22, 2011, under Application No. 13/053,338.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8637747&OS=8637747&RS=8637747

For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com

(c) 2014 US Fed News (HT Syndication)

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.